FDA Clearance Tracker · P010058
OSTEOSPACE
Last checked: Nov 21, 2026Latest source record: Mar 15, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Mar 15, 2004
Approved (reclassified)
Time to decision
894 days
Received Oct 3, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class II
The decision
- FDA number
- P010058
- Device name
- OSTEOSPACE
- Applicant
- Medilink
- Applicant location
- Carnon
- Received
- Oct 3, 2001
- Decided
- Mar 15, 2004
- Decision
- Approved (reclassified)
Device type
- Device type
- Bone sonometer (MUA)
- Device class
- Class II
- Regulation
- 21 CFR 892.1180
- Specialty
- Radiology & Imaging
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE OSTEOSPACE. THE OSTEOSPACE IS A QUANTITATIVE ULTRASOUND BONE SONOMETER DEVICE (QUS) TO BE USED FOR THE MEASUREMENT OF BROADBAND ULTRASOUND ATTENUATION (BUA) OF THE CALCANEUS, AS AN AID, TOGETHER WITH OTHER CLINICAL RISK FACTORS, TO DIAGNOSE OSTEOPOROSIS AND OTHER MEDICAL CONDITIONS LEADING TO REDUCED BONE STRENGTH AND TO ESTIMATE THE RISK OF SUBSEQUENT ATRAUMATIC FRACTURE. THE OUTPUT IS EXPRESSED IN TERMS OF BUA, T-SCORE, AND Z-SCORE.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MUA. The earliest in FDA's data is P970017, decided Mar 12, 1998.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medilink
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Hydrozid510(k)
K201740 · Decided Jul 7, 2021 · 377 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.